Stockscreener 앱 받기
28.36
1.58%
0.44
시장 영업 전:
29.40
1.04
+3.67%
전일 마감가:
$27.92
열려 있는:
$27.93
하루 거래량:
346.80K
Relative Volume:
1.08
시가총액:
$1.28B
수익:
$45.95M
순이익/손실:
$-48.88M
주가수익비율:
-25.48
EPS:
-1.1129
순현금흐름:
$109.67M
1주 성능:
+5.23%
1개월 성능:
+9.67%
6개월 성능:
+10.95%
1년 성능:
+199.16%
1일 변동 폭
$27.93
$29.89
1주일 범위
$25.79
$29.89
52주 변동 폭
$9.045
$32.63
Septerna Inc Stock (SEPN) Company Profile
명칭
Septerna Inc
전화
650-338-3533
주소
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO
Compare SEPN vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SEPN
Septerna Inc
|
28.36 | 1.26B | 45.95M | -48.88M | 109.67M | -1.1129 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Septerna Inc Stock (SEPN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-19 | 개시 | Raymond James | Strong Buy |
| 2025-12-15 | 개시 | Truist | Buy |
| 2025-11-14 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2025-06-23 | 개시 | H.C. Wainwright | Buy |
| 2025-02-18 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-11-19 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-19 | 개시 | JP Morgan | Overweight |
| 2024-11-19 | 개시 | TD Cowen | Buy |
| 2024-11-19 | 개시 | Wells Fargo | Overweight |
모두보기
Septerna Inc 주식(SEPN)의 최신 뉴스
SEPN Q1 2026 Earnings: Smaller-Than-Expected Loss Amidst Pipeline ProgressEarnings Revision Downgrade - Newser
SEPN Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineExpert Momentum Signals - Newser
Septerna Inc. (SEPN) Q1 2026 Earnings: Smaller-than-Expected Loss Drives Positive Market ResponseCommunity Pattern Alerts - Newser
Septerna Inc. (SEPN) Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost DisciplineROA Comparison - Newser
New Forecasts: Here's What Analysts Think The Future Holds For Septerna, Inc. (NASDAQ:SEPN) - Sahm
Septerna, Inc. (SEPN) Competitors - Meyka
Septerna (SEPN) Q1 2026 Crushes Forecasts — EPS $-0.19 vs $-0.42Free Stock Community - Newser
Why Septerna (SEPN) Is Up 11.6% After Q1 Revenue Surge And Narrowed Losses - simplywall.st
Party Time: Brokers Just Made Major Increases To Their Septerna, Inc. (NASDAQ:SEPN) Earnings Forecasts - Yahoo Finance
Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported And Analysts Are Boosting Their Estimates - Yahoo Finance
Q2 Earnings Forecast for Septerna Issued By HC Wainwright - MarketBeat
TradingKey - TradingKey
Earnings Update: Septerna, Inc. (NASDAQ:SEPN) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts - simplywall.st
Septerna Inc. (SEPN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Septerna, Inc. (SEPN) reports Q1 loss, tops revenue estimates - MSN
H.C. Wainwright reiterates Septerna stock rating at buy, $40 target By Investing.com - Investing.com South Africa
H.C. Wainwright reiterates Septerna stock rating at buy, $40 target - Investing.com
Septerna (SEPN) Q1 Loss Narrows To US$8.6 Million Challenging Bearish Earnings Narratives - Sahm
Wells Fargo Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $48 - Moomoo
TD Cowen Maintains Septerna(SEPN.US) With Buy Rating - Moomoo
Septerna Highlights Business Progress and Reports First Quarter 2026 Financial Results - The Manila Times
Wells Fargo Upgrades Septerna (SEPN) - MSN
Septerna, Inc. (SEPN) Reports Q1 Loss, Tops Revenue Estimates - sharewise.com
Septerna Q1 revenue rises sharply helped by Novo Nordisk collaboration - TradingView
Septerna (NASDAQ: SEPN) grows Q1 revenue to $26.5M, trims loss - Stock Titan
Septerna, Inc. 1Q 2026: Revenue $26.5M, EPS $(0.19) — 10-Q Summary - TradingView
Septerna, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Earnings Flash (SEPN) Septerna, Inc. Reports Q1 Revenue $26.5M, vs. FactSet Est of $17.0M - marketscreener.com
Septerna (SEPN) Q1 2026 revenue jumps on Novo Nordisk deal, loss narrows - Stock Titan
Septerna moves chronic hives pill toward Phase 2 after Phase 1 study - Stock Titan
HC Wainwright & Co. Maintains Septerna (SEPN) Buy Recommendation - MSN
How Analyst Upgrade and Conference Spotlight Will Impact Septerna (SEPN) Investors - Yahoo Finance
Septerna, Inc. (SEPN) Stock Analysis: Unpacking a Potential 84% Upside in the Healthcare Biotech Arena - DirectorsTalk Interviews
Should you add Septerna (SEPN) to your watchlist today? (Weakens) 2026-05-07Continuation Pattern - newser.com
Septerna to Present at Bank of America Securities Health Care Conference - The Manila Times
Septerna CEO to give webcast presentation from Las Vegas on May 12 - Stock Titan
Septerna, Inc. ($SEPN) CEO 2025 Pay Revealed - Quiver Quantitative
Stifel Maintains Septerna(SEPN.US) With Buy Rating, Maintains Target Price $43 - Moomoo
Septerna (NASDAQ:SEPN) Now Covered by Stifel Nicolaus - MarketBeat
Septerna, Inc. (NASDAQ:SEPN) Sees Significant Growth in Short Interest - MarketBeat
Stifel Initiates Septerna(SEPN.US) With Buy Rating, Announces Target Price $43 - Moomoo
Septerna | DEF 14A: Definitive information statements - Moomoo
Septerna (NASDAQ: SEPN) details 2026 vote on directors and auditor - Stock Titan
Septerna, Inc. (SEPN) reports Q4 loss, tops revenue estimates - MSN
[ARS] Septerna, Inc. SEC Filing - Stock Titan
Septerna (SEPN) price target increased by 34.39% to 46.41 - MSN
Septerna Inc (SEPN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.98%
1.33%
자본화:
|
볼륨(24시간):